News | November 15, 2023
JB Pharma Q2 FY24 PAT up 36% to Rs. 151 Cr
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
The Main campaign started from October 2
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
India is promoting holistic healthcare with emphasis on preventive care
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Subscribe To Our Newsletter & Stay Updated
